With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

Merck , known as MSD outside of the United States and Canada, announced that Canada's Drug Agency (CDA) has recommended WINREVAIR® (sotatercept) for reimbursement in combination with standard ...

AstraZeneca’s presence in South Africa has become a driving force in global health research, contributing significantly to respiratory, cardiovascular, and oncology therapeutic areas. The ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

During the ongoing Singles’ Day Grand Promotion, sales of cross-border products have surged ... aging for the “silver economy ...

SEC filing, will be determined "based on the book-building process" — but Medicus said it is expected to be close to the ...

Sarepta Therapeutics is advancing SRP-9003 gene therapy for LGMD, with phase 3 study results expected in early 2025. Learn ...

September is Global Diversity and Inclusion month – David Peacock, managing director of MSD in the UK shares with ... Discover how AI is transforming the pharma commercial strategy.

Two dietary supplements, sold to support men's health, have been recalled due to undeclared "hidden drug ingredients," the U.S. Food and Drug Administration says.The unlisted ingredients can cause ...

(Bloomberg) -- Drugmakers are slow-walking products to market to get around President Joe Biden’s plan to lower medication prices. Companies from Roche Holding AG to biotech Alnylam Pharmaceuticals ...